| Medical and Health Sciences | Lifetime | 683 | GB 74 | 99.97 |
| Mathematics and Statistics | Lifetime | 610 | GB 53 | 99.06 |
| Mathematics and Statistics | 2021-2025 | 792 | GB 42 | 92.57 |
| Medical Physiology | Lifetime | 194 | GB 20 | 99.70 |
| Health | Lifetime | 81 | GB 15 | 99.47 |
| Pulmonary and Respiratory Medicine | Lifetime | 431 | GB 32 | 99.43 |
| General Health Professions | Lifetime | 704 | GB 112 | 99.20 |
| Health, Toxicology and Mutagenesis | Lifetime | 226 | GB 20 | 99.09 |
| Public, Environmental and Occupational Health | Lifetime | 755 | GB 81 | 98.93 |
| Statistics and Probability | Lifetime | 214 | GB 23 | 98.48 |
| Speech and Hearing | Lifetime | 330 | GB 31 | 96.71 |
| Emergency Medical Services | Lifetime | 673 | GB 64 | 92.81 |
| Immunology and Allergy | Lifetime | 592 | GB 56 | 88.57 |
| Modeling and Simulation | Lifetime | 443 | GB 29 | 87.38 |
| Pharmacology | Lifetime | 989 | GB 90 | 72.85 |
| Econometrics and Quantitative Economics | 2021-2025 | 838 | GB 66 | 94.55 |
| Infectious Diseases | 2021-2025 | 762 | GB 66 | 81.35 |
| Statistics and Probability | 2021-2025 | 281 | GB 22 | 80.06 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 846 | GB 66 | 76.78 |
| Modeling and Simulation | 2021-2025 | 334 | GB 17 | 70.03 |
| Asthma and respiratory diseases | Lifetime | 70 | GB 15 | 99.76 |
| Occupational and environmental lung diseases | Lifetime | 23 | GB 6 | 99.45 |
| Global Public Health Policies and Epidemiology | Lifetime | 49 | GB 10 | 99.12 |
| Health disparities and outcomes | Lifetime | 128 | GB 29 | 99.26 |
| Respiratory and Cough-Related Research | Lifetime | 70 | GB 17 | 99.48 |
| Health, Environment, Cognitive Aging | Lifetime | 41 | GB 13 | 99.07 |
| Occupational exposure and asthma | Lifetime | 50 | GB 6 | 98.61 |
| Advanced Causal Inference Techniques | Lifetime | 38 | GB 7 | 98.05 |
| Pediatric health and respiratory diseases | Lifetime | 205 | GB 30 | 98.51 |
| Air Quality and Health Impacts | Lifetime | 506 | GB 36 | 98.76 |
| Allergic Rhinitis and Sensitization | Lifetime | 285 | GB 37 | 98.78 |
| T-cell and Retrovirus Studies | Lifetime | 161 | GB 10 | 98.07 |
| COVID-19 and healthcare impacts | Lifetime | 318 | GB 57 | 95.85 |
| Global Cancer Incidence and Screening | Lifetime | 428 | GB 39 | 97.90 |
| COVID-19 epidemiological studies | Lifetime | 442 | GB 60 | 96.94 |
| Vaccine Coverage and Hesitancy | Lifetime | 456 | GB 40 | 97.03 |
| Indoor Air Quality and Microbial Exposure | Lifetime | 234 | GB 10 | 96.94 |
| Climate Change and Health Impacts | Lifetime | 563 | GB 65 | 96.43 |
| Carcinogens and Genotoxicity Assessment | Lifetime | 654 | GB 44 | 96.95 |
| Statistical Methods in Clinical Trials | Lifetime | 452 | GB 68 | 94.98 |
| Delphi Technique in Research | Lifetime | 472 | GB 119 | 91.55 |
| Statistical Methods and Bayesian Inference | Lifetime | 554 | GB 56 | 93.89 |
| Chemical Safety and Risk Management | Lifetime | 194 | GB 17 | 90.27 |
| demographic modeling and climate adaptation | Lifetime | 393 | GB 82 | 88.40 |
| Agriculture and Farm Safety | Lifetime | 560 | GB 41 | 87.79 |
| Statistical Methods in Epidemiology | Lifetime | 18 | GB 5 | 90.64 |
| Historical and modern epidemiology studies | Lifetime | 32 | GB 5 | 81.95 |
| COVID-19 and healthcare impacts | 2021-2025 | 139 | GB 33 | 96.89 |
| Infection Control and Ventilation | 2021-2025 | 402 | GB 31 | 85.54 |